Skip to main content
. 2012 Aug 30;8(8):e1002665. doi: 10.1371/journal.pcbi.1002665

Table 1. Comparison of experimental ΔΔG in oseltamivir and zanamivir for three NA mutations with estimates obtained using different computational approaches.

Method H274Y N294S Y252H RMSE
ΔΔG, kcal/mol ΔΔG, kcal/mol ΔΔG, kcal/mol (RMSD), kcal/mol
zanamivir oseltamivir zanamivir oseltamivir zanamivir oseltamivir
Experimentala 0.4 (0.1) 3.3 (0.2) * 1.2 (0.1) * 2.6 (0.2) * 0.1 (0.2) −1.4 (0.1) N/A (0.2)
SRMM −5.8 (7.4) 0.7 (7.0) 8.2 (7.7) 5.8 (6.2) −0.1 (8.7) −0.9 (7.4) 4.2 (7.4)
SRSM 1.7 (2.9) 1.2 (3.0) 0.6 (2.0) 1.7 (1.9) 1.5 (1.7) 0.5 (1.5) 1.5 (2.2)
SRSM/HREX 1.3 (0.8) 4.1 (2.4) 2.3 (0.4) 2.2 (0.9) 0.6 (0.8) 0.7 (1.4) 1.1 (1.1)
MM-GBSA 6.2 (8.1) 0.9 (3.8) 5.7 (6.1) −5.9 (3.6) 2.1 (2.9) −1.9 (3.0) 4.8 (4.6)
MM-PBSA 8.4 (10.1) 3.0 (3.9) 5.8 (4.5) −4.7 (3.2) 2.8 (3.1) 0.2 (2.6) 5.0 (4.6)
Rosetta −0.4 (0.5) 0.8 (0.4) −0.4 (0.3) 0.3 (0.2) −0.1 (0.4) 0.0 (0.0) 1.7 (0.3)
a

Values were derived from the data reported by Collins et al [10].

Standard deviations are shown in parentheses. Root mean squared error (RMSE) and the RMS Standard Deviation (RMSD) are provided.

‘*’

indicates experimentally determined drug resistant mutation. ‘N/A’ stands for not applicable.